Richard A. Heyman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Del Mar, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Christian Kuhlen, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Richard A. Heyman

Form 4 holding Director

RayzeBio, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
26 Feb 2024
Price
$62.50
Ownership
Direct
Form 4 holding Director

Gritstone bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
19,000
Estimated value
Report date
17 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Metacrine, Inc.

Security class
Stock Option (right to buy)
Shares / value
16,500
Estimated value
Report date
18 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

YUMANITY THERAPEUTICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
14,800
Estimated value
Report date
02 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Richard A. Heyman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .